Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXU
7351
DELISTED
Alexco Resource Corp
AXU
| $381K | ﹤0.01% |
169,289
+3,857
| +2% | +$7.14K |
|
7352
CALL
Black Hills Corp
BKH
$5.66B
| $380K | ﹤0.01% |
6,700
+2,400
| +56% | +$145K |
|
7353
HealthStream
HSTM
$846M
| $380K | ﹤0.01% |
17,163
+7,778
| +83% | +$180K |
|
7354
MetLife
MET
$62.1B
| $380K | ﹤0.01% |
10,400
-3,703,120
| -100% | -$129M |
|
7355
CALL
World Acceptance Corp
WRLD
$908M
| $380K | ﹤0.01% |
5,800
+1,600
| +38% | +$100K |
|
|
WRI
7356
PUT
DELISTED
Weingarten Realty Investors
WRI
| $380K | ﹤0.01% |
+20,100
| New | +$352K |
|
7357
Collegium Pharmaceutical
COLL
$875M
| $379K | ﹤0.01% |
21,646
-125,519
| -85% | -$2.46M |
|
|
FLNA
7358
Filana Therapeutics
FLNA
$44.1M
| $379K | ﹤0.01% |
123,049
+105,276
| +592% | +$477K |
|
|
RVNC
7359
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
| $379K | ﹤0.01% |
15,500
-700
| -4% | -$13.8K |
|
|
JOBS
7360
DELISTED
51job Inc
JOBS
| $379K | ﹤0.01% |
5,281
-12,114
| -70% | -$795K |
|
|
TFIV
7361
DELISTED
Global X TargetIncome 5 ETF
TFIV
| $379K | ﹤0.01% |
17,118
-19,885
| -54% | -$432K |
|
7362
RE/MAX Holdings
RMAX
$268M
| $378K | ﹤0.01% |
12,032
+1,567
| +15% | +$41.6K |
|
7363
Ultrapar
UGP
$6.56B
| $378K | ﹤0.01% |
111,437
+32,055
| +40% | +$94.4K |
|
7364
PUT
Ichor Holdings
ICHR
$2.66B
| $377K | ﹤0.01% |
14,200
-14,700
| -51% | -$336K |
|
7365
CALL
Sonic Automotive
SAH
$2.56B
| $377K | ﹤0.01% |
+11,800
| New | +$272K |
|
|
ATHX
7366
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
| $377K | ﹤0.01% |
5,464
+4,848
| +787% | +$337K |
|
7367
CALL
AAR Corp
AIR
$5.85B
| $376K | ﹤0.01% |
+18,200
| New | +$352K |
|
7368
PUT
WPP
WPP
$5.8B
| $376K | ﹤0.01% |
9,600
-2,800
| -23% | -$104K |
|
|
GLOP
7369
PUT
DELISTED
GASLOG PARTNERS LP
GLOP
| $376K | ﹤0.01% |
91,800
-13,600
| -13% | -$59.3K |
|
|
CN
7370
DELISTED
Xtrackers MSCI All China Equity ETF
CN
| $376K | ﹤0.01% |
10,591
+2,418
| +30% | +$79.9K |
|
7371
Haverty Furniture Companies
HVT
$449M
| $375K | ﹤0.01% |
23,407
+2,291
| +11% | +$33.4K |
|
7372
PUT
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$39.8M
| $375K | ﹤0.01% |
540
+167
| +45% | +$210K |
|
7373
PUT
Regal Rexnord
RRX
$11.7B
| $375K | ﹤0.01% |
+4,300
| New | +$322K |
|
7374
SP Funds S&P 500 Sharia ETF
SPUS
$3.08B
| $375K | ﹤0.01% |
+17,890
| New | +$350K |
|
|
RVNC
7375
DELISTED
Revance Therapeutics, Inc.
RVNC
| $375K | ﹤0.01% |
15,347
-432
| -3% | -$8.53K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.